Loading…

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

meRfi® AI Chat

NCT02957591 - Bifidobacterium animalis lactis DSM 24737 / NCIMB 30436 + Bifidobacterium breve DSM 24732 / NCIMB 30441 + Bifidobacterium longum DSM 24736 / NCIMB 30435 + Lacticaseibacillus paracasei DSM 24733 + Lactiplantibacillus plantarum DSM 24730 + Lactobacillus acidophilus DSM 24735 / NCIMB 30442 + Lactobacillus delbrueckii bulgaricus DSM 24734 + Streptococcus thermophilus DSM 24731& Major depressive disorder / Major Depression / Depressive episode (MDD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background

The microbiota-gut-brain (MGB) axis, which is associated with physiological and behavioral functions impacted in major depressive disorder (MDD), is the focus of a promising new treatment approach for MDD (1)

Study overview

It is a double-blind randomized clinical treatment trial studying [Bifidobacterium animalis lactis DSM 24737 / NCIMB 30436 + Bifidobacterium breve DSM 24732 / NCIMB 30441 + Bifidobacterium longum DSM 24736 / NCIMB 30435 + Lacticaseibacillus paracasei DSM 24733 + Lactiplantibacillus plantarum DSM 24730 + Lactobacillus acidophilus DSM 24735 / NCIMB 30442 + Lactobacillus delbrueckii bulgaricus DSM 24734 + St…

References (Sources)

Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
Schaub et al. 2022 Transl Psychiatry 12: 227

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!